[
  {
    "ts": null,
    "headline": "Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?",
    "summary": "Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=1fd395e360db6e065ad0648bf8d55ec1c9d9a6aedc5f56548278c9fa8c063f60",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748619069,
      "headline": "Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?",
      "id": 134908686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=1fd395e360db6e065ad0648bf8d55ec1c9d9a6aedc5f56548278c9fa8c063f60"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences: Overbought Given Current Growth Prospects",
    "summary": "Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW stock prospects.",
    "url": "https://finnhub.io/api/news?id=0503547251de3e5fe6e8807414e4768df32c9a832e996533a1c2066ce41cae34",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748612394,
      "headline": "Edwards Lifesciences: Overbought Given Current Growth Prospects",
      "id": 134906049,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/814479208/image_814479208.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW stock prospects.",
      "url": "https://finnhub.io/api/news?id=0503547251de3e5fe6e8807414e4768df32c9a832e996533a1c2066ce41cae34"
    }
  }
]